Skip to main content

Table 1 Out of a total of 9951 patients presenting with cardiac CEDIS complaints, 82.1 and 81.9% of patients, respectively, had hsTnT and CK measured. Chest Pain (Cardiac Features) prompted biomarker testing most frequently. 1.2% of patients presenting to the ED were subsequently admitted with diagnoses of NSTE-ACS. hsTnT; high-sensitivity troponin T, CK; creatine kinase, NSTE-ACS; non-ST-elevation ACS

From: Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes

 

Total Patients

Prevalence (n = 36,251)

hsTnT Measured

CK Measured

Chest Pain

404

1.1%

96.3%

95.8%

Chest Pain (Cardiac Features)

3555

9.8%

97.6%

97.4%

Chest Pain (Non-cardiac Features)

1040

2.9%

67.5%

67.4%

Generalized Weakness

746

2.1%

62.6%

62.9%

Palpitations

1033

2.8%

88.2%

87.8%

Shortness of Breath

1600

4.4%

68.2%

68.2%

Syncope

709

2.0%

75.9%

75.7%

Vertigo

437

1.2%

39.6%

39.1%

Admitted with NSTE-ACS (any CEDIS complaint)

427

1.2%

100%

100%

Combined

9951

27.5%

82.1%

81.9%